Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCTa070250146Recruiting
Open-label, single-arm trial in Cirrhosis, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Adverse events and device malfunctions through 1 month after CLP-001 transplantation. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCTa070250146.